APA (7th ed.) Citation

EK, L., J, T., JR, G., MI, L., JX, L., P, L., . . . JB, S. (2024). Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity. JCI insight, 9(18), . https://doi.org/10.1172/jci.insight.173469

Chicago Style (17th ed.) Citation

EK, Leonard, et al. "Engineered Cytokine/antibody Fusion Proteins Improve IL-2 Delivery to Pro-inflammatory Cells and Promote Antitumor Activity." JCI Insight 9, no. 18 (2024). https://doi.org/10.1172/jci.insight.173469.

MLA (9th ed.) Citation

EK, Leonard, et al. "Engineered Cytokine/antibody Fusion Proteins Improve IL-2 Delivery to Pro-inflammatory Cells and Promote Antitumor Activity." JCI Insight, vol. 9, no. 18, 2024, https://doi.org/10.1172/jci.insight.173469.